Aktienanalyse zu DocGo Inc (DCGO)DCGODocGo Inc

DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

DocGo Inc. is not a good buy right now. The current price is $0.2474, and the company has reported significant losses, with a net income loss of $15.82 million in Q2 2026, worsening from a $11.16 million loss last year. The RSI is at 41.90, indicating a lack of momentum for a potential upward trend. Additionally, the stock is down 72.14% year-to-date, reflecting ongoing financial struggles and market skepticism.